SCHEMBL19081571

SCHEMBL19081571

c1ccc2cc(-c3c4ccccc4c(-c4ccc(-c5ccc6oc7c(ccc8c7oc7ccc9ccccc9c78)c6c5)cc4)c4ccccc34)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 2/20 0.40
CYP1B1 Q16678 1/20 0.40
ABCG2 Q9UNQ0 3/20 0.37
TDP1 Q9NUW8 4/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
PAX8 Q06710 2/20 0.36
CYP1A2 P05177 2/20 0.36
AHR P35869 2/20 0.36
FYN P06241 1/20 0.36
MAPK3 P27361 1/20 0.36
NPC1 O15118 3/20 0.36
RAB9A P51151 2/20 0.36
ESR1 P03372 1/20 0.36
ESR2 Q92731 1/20 0.36
KDM4E B2RXH2 2/20 0.35
MAPT P10636 2/20 0.35
GLA P06280 1/20 0.35
HPGD P15428 1/20 0.35
TSHR P16473 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081460 0.96 CYP1A1 (0.43) CYP1A1CYP1B1ABCG2TDP1L3MBTL1
SCHEMBL19081624 0.95 ABCG2 (0.42) CYP1A1CYP1B1ABCG2TDP1L3MBTL1
SCHEMBL19081577 0.93 CYP1A1 (0.40) CYP1A1CYP1B1ABCG2TDP1L3MBTL1
SCHEMBL19081493 0.92 ABCG2 (0.44) CYP1A1CYP1B1ABCG2TDP1L3MBTL1
SCHEMBL19081565 0.91 CYP1A1 (0.40) CYP1A1CYP1B1ABCG2TDP1L3MBTL1
SCHEMBL10122447 0.91 CYP1A1 (0.40) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2
SCHEMBL10122403 0.91 CYP1A1 (0.40) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2
SCHEMBL10122405 0.91 CYP1A1 (0.40) CYP1A1CYP1B1TDP1L3MBTL1CYP1A2
SCHEMBL16067730 0.91 CYP1A1 (0.49) CYP1A1CYP1B1ABCG2TDP1L3MBTL1
SCHEMBL16067845 0.91 CYP1A1 (0.49) CYP1A1CYP1B1ABCG2TDP1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ABCG2 4823/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 CYP1A1 184/4885CYP1B1 260/4885ABCG2 4823/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.